Product Description: Tezepelumab (AMG 157) is human monoclonal antibody (IgG2λ) that binds specifically to TSLP, blocking it from interacting with its heterodimeric receptor. Tezepelumab can be used for the research of severe, uncontrolled asthma[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Menzies-Gow A, et, al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N Engl J Med. 2021 May 13;384(19):1800-1809.
CAS Number: 1572943-04-4
Molecular Weight: N/A
Compound Purity: 95.0
Research Area: Inflammation/Immunology
Solubility: H2O
Target: Others